Categories: News

NYSE Content Advisory: Pre-Market Update + Evommune Rises in Trading Debut

NEW YORK, Nov. 7, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Kristen Scholer delivers the pre-market update on November 7th

- Advertisement -
  • Equities are lower Friday morning after the major indices retreated Thursday in a volatile session. The S&P 500 shed 1.1% as signs of a cooling jobs market pushed down tech stocks and cryptocurrency.
  • Traders scooped up bonds amid bets that the Federal Reserve will cut interest rates due to a softening labor market. The Central Bank has one final meeting scheduled this year in Mid-December.
  • NYSE IPO’s Evommune and Grupo Aeromexico popped on their first day of trading yesterday. Evommune rallied 26% in its debut while Aeromexico rose 7.1%.


Opening Bell


PENCIL celebrates its 30th anniversary

- Advertisement -


Closing Bell


World Leaders in Data and AI (WLDA) celebrates the 2025 WLDA Summit

- Advertisement -


Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2817101/NYSE_Nov_7_Market_Update.mp4 
Logo – https://mma.prnewswire.com/media/2581322/5609335/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–evommune-rises-in-trading-debut-302608704.html

- Advertisement -

Recent Posts

Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference

May 21, 2026 07:05 ET  | Source: Lifecore Biomedical, Inc. CHASKA, Minn., May 21, 2026…

16 minutes ago

Vitacore Announces World-First Custom-Fit CPAP Mask Following Health Canada MDL Approval

VANCOUVER, British Columbia, May 21, 2026 (GLOBE NEWSWIRE) -- Vitacore, a deep technology company, today…

16 minutes ago

Infex Therapeutics announces positive Phase IIa results for RESP-X in non-cystic fibrosis bronchiectasis patients colonised with Pseudomonas aeruginosa

Study met its primary objective demonstrating excellent safety and tolerability, of RESP-X in patients with…

16 minutes ago

Cantor Receives ADGM Approval, Expanding Middle East Investment Banking Platform

Strengthens cross-border investment and capital formation capabilities connecting the Middle East with global marketsNEW YORK…

17 minutes ago

IBM and U.S. Department of Commerce Announce America’s First Purpose-Built Quantum Foundry, Supported by Proposed $1 Billion CHIPS Award

Powered by IBM's decades-long quantum leadership, initiative will accelerate American quantum innovation and enable advanced…

17 minutes ago

Solar & wind expansion set to trigger USD 10-15 Billion land investments by 2030: Colliers India

India's renewable energy capacity stood at 251 GW in 2025; solar & wind together account…

17 minutes ago